# BCTX (Briacell Therapeutics Corp.) - SEC EDGAR Financial Statements

> Briacell Therapeutics Corp. reported $23.58M in total assets and a net loss of $34.90M through July 31, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BCTX
- Markdown: https://convexityos.com/fundamentals/BCTX.md
- SEC CIK: 0001610820
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001610820&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Jul 31, 2026 |
| Operating Income | FY 2026 | -$36.05M | Operating profit |
| Net Income | FY 2026 | -$34.90M | GAAP bottom line |
| Diluted EPS | FY 2026 | -$6.97 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$28.78M | Operating CF less CapEx |
| Cash & ST Investments | Jul 31, 2026 | $20.54M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $29.24M | $21.27M | $27.18M | $15.34M | $8.02M | $2.02M |
| Total Operating Expenses | $36.05M | $27.20M | $33.33M | $23.27M | -- | -- |
| **Operating Income** | -$36.05M | -$27.20M | -$33.33M | -$23.27M | -$15.29M | -$6.98M |
| **EBITDA** | -$35.93M | -$27.10M | -$33.25M | -- | -$15.27M | -$6.96M |
| Interest Income | $634K | $120K | $288K | $891K | $137K | $3.1K |
| Interest Expense | $30K | $37K | -- | -- | $979 | $79K |
| Income Before Tax | $35.33M | $26.56M | $4.93M | $20.30M | -$26.84M | -$13.82M |
| **Net Income** | -$34.90M | -$26.31M | -$4.79M | -$20.30M | -$26.84M | -$13.82M |
| Basic EPS | -$6.97 | -$62.19 | -$436.80 | -$29,104.48 | -$38,731.34 | -$68,507.46 |
| **Diluted EPS** | -$6.97 | -$62.19 | -$436.80 | -$29,104.48 | -$38,731.34 | -- |
| Basic Shares Outstanding | 5.0M | 423.1K | 11.0K | 698 | 692 | 202 |
| Diluted Shares Outstanding | 5.0M | 423.1K | 11.0K | 698 | 692 | -- |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $10.53M | $5.97M | $6.05M | $6.68M | $7.11M | $4.81M | $5.68M | $3.67M |
| Total Operating Expenses | $12.58M | $7.62M | $7.53M | $8.32M | $8.55M | $6.33M | $7.17M | $5.15M |
| **Operating Income** | -$12.58M | -$7.62M | -$7.53M | -$8.32M | -$8.55M | -$6.33M | -$7.17M | -$5.15M |
| **EBITDA** | -$12.55M | -$7.59M | -$7.50M | -$8.30M | -$8.53M | -$6.30M | -$7.14M | -$5.13M |
| Interest Income | $171K | $219K | $106K | $48K | $33K | $27K | $47K | $13K |
| Interest Expense | -- | $30K | -- | -- | -- | $37K | -- | -- |
| **Net Income** | -$12.32M | -$7.16M | -$7.22M | -$8.20M | -$8.09M | -$6.13M | -$6.29M | -$5.80M |
| Basic EPS | -- | -$0.99 | -$2.58 | -$43.50 | -- | -$16.42 | -$23.31 | -$326.70 |
| **Diluted EPS** | -- | -$0.99 | -$2.58 | -$43.50 | -- | -$16.42 | -$23.31 | -$326.70 |
| Basic Shares Outstanding | -- | 7.3M | 2.8M | 188.4K | -- | 373.1K | 270.0K | 17.8K |
| Diluted Shares Outstanding | -- | 7.3M | 2.8M | 188.4K | -- | 373.1K | 270.0K | 17.8K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.85M | $10.49M | $862K | $21.25M | $41.04M | $57.27M |
| Short-Term Investments | $10.69M | $7.37M | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $20.54M | $17.87M | $862K | $21.25M | $41.04M | $57.27M |
| Accounts Receivable, Net | -- | -- | -- | $19K | $24K | $13K |
| **Total Current Assets** | $22.04M | $19.93M | $3.65M | $26.95M | $42.35M | $57.80M |
| Property, Plant & Equipment, Net | $320K | $297K | $388K | $2.5K | $2.5K | -- |
| Intangible Assets | $169K | $185K | $200K | $215K | $230K | $246K |
| **Total Non-Current Assets** | $1.53M | $1.72M | $2.22M | $215K | $230K | $246K |
| **Total Assets** | $23.58M | $21.65M | $5.87M | $27.16M | $42.58M | $58.04M |
| Accounts Payable | $6.99M | $3.28M | $7.17M | $1.12M | $463K | $214K |
| **Total Current Liabilities** | $7.98M | $3.98M | $7.46M | $1.80M | $941K | $557K |
| **Total Non-Current Liabilities** | $39K | $338K | $1.10M | $29.14M | $31.31M | $29.82M |
| **Total Liabilities** | $8.02M | $4.32M | $8.56M | $30.94M | $32.25M | $30.37M |
| Common Stock | $120.9M | $101.7M | $72.17M | $69.59M | $65.59M | $54.77M |
| Retained Earnings | -$146.7M | -$111.8M | -$85.44M | -$80.65M | -$60.35M | -$29.14M |
| Accumulated Other Comp. Income | -$139K | -$139K | -$139K | -$139K | -$139K | -$139K |
| **Total Stockholders' Equity** | -- | -- | -- | -$3.78M | $10.33M | $27.67M |
| Total Equity | $15.56M | $17.33M | -$2.68M | -$3.78M | $10.33M | $27.67M |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.85M | $6.88M | $29.90M | $2.71M | $10.49M | $12.46M | $5.01M | $5.79M |
| Short-Term Investments | $10.69M | $15.92M | -- | $7.46M | $7.37M | -- | -- | -- |
| **Cash & Short-Term Investments** | $20.54M | $22.80M | $29.90M | $10.18M | $17.87M | $12.46M | $5.01M | $5.79M |
| **Total Current Assets** | $22.04M | $25.39M | $32.18M | $11.35M | $19.93M | $14.79M | $7.16M | $8.22M |
| Property, Plant & Equipment, Net | $320K | $349K | $251K | $274K | $297K | $320K | $342K | $365K |
| Intangible Assets | $169K | -- | -- | $181K | $185K | $188K | $192K | $196K |
| **Total Non-Current Assets** | $1.53M | $1.68M | $1.42M | $1.73M | $1.72M | $2.22M | $2.20M | $2.20M |
| **Total Assets** | $23.58M | $27.07M | $33.59M | $13.08M | $21.65M | $17.00M | $9.36M | $10.41M |
| Accounts Payable | $6.99M | $2.17M | $1.88M | $2.13M | $3.28M | $3.28M | $5.00M | $4.23M |
| **Total Current Liabilities** | $7.98M | $3.59M | $3.19M | $3.32M | $3.98M | $4.33M | $5.23M | $4.99M |
| **Total Non-Current Liabilities** | $39K | $72K | $195K | $407K | $338K | $730K | $906K | $1.71M |
| **Total Liabilities** | $8.02M | $3.66M | $3.38M | $3.72M | $4.32M | $5.06M | $6.14M | $6.70M |
| Common Stock | $120.9M | $117.1M | $117.1M | $101.7M | $101.7M | $94.02M | $85.45M | $82.04M |
| Retained Earnings | -$146.7M | -$134.3M | -$127.2M | -$120.0M | -$111.8M | -$103.7M | -$97.54M | -$91.25M |
| Accumulated Other Comp. Income | -$139K | -$139K | -$139K | -$139K | -$139K | -$139K | -$139K | -$139K |
| Total Equity | $15.56M | $23.41M | $30.21M | $9.35M | $17.33M | $11.94M | $3.23M | $3.71M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$35.33M | -$26.56M | -$4.93M | -$20.30M | -$26.84M | -$13.82M |
| Depreciation & Amortization | $119K | $107K | $84K | -- | $15K | $15K |
| Stock-Based Compensation | $1.13M | $657K | $1.80M | $2.19M | $3.07M | $1.97M |
| Change in Receivables | -$3.2K | $734K | -$733K | $5.2K | -$12K | $9.9K |
| Change in Payables | $3.71M | -$3.89M | $6.05M | $660K | $249K | -$1.41M |
| **Operating Cash Flow** | -$28.65M | -$28.17M | -$24.13M | -$23.74M | -$12.48M | -$7.75M |
| Capital Expenditure | -$127K | -- | -$457K | -- | -- | -- |
| **Free Cash Flow** | -$28.78M | -- | -$24.58M | -- | -- | -- |
| Purchases of Investments | -$377K | -$330K | -$225K | -- | -- | -- |
| **Investing Cash Flow** | -$3.81M | -$7.65M | -$682K | -- | -- | -- |
| Common Stock Issued | $31.81M | $44.63M | $4.42M | $4.00M | -- | -- |
| Share Repurchases | -- | -- | -- | -$47K | -$10.17M | -- |
| **Financing Cash Flow** | $31.81M | $45.45M | $4.42M | $3.95M | -$3.74M | $65.00M |
| **Net Change in Cash** | -$641K | $9.63M | -$20.39M | -$19.79M | -$16.23M | $57.25M |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.51M | -$7.24M | -$7.30M | -$8.28M | -$8.16M | -$6.22M | -$6.34M | -$5.83M |
| Depreciation & Amortization | $33K | $33K | $27K | $27K | $27K | $27K | $27K | $27K |
| Stock-Based Compensation | $118K | $432K | $286K | $295K | -$120K | $225K | $285K | $267K |
| Change in Receivables | -- | -- | -- | -- | $514 | $9.9K | -$14K | $737K |
| Change in Payables | $4.82M | $295K | -$249K | -$1.15M | $4.5K | -$1.72M | $769K | -$2.94M |
| **Operating Cash Flow** | -$5.96M | -$7.02M | -$7.97M | -$7.70M | -$8.13M | -$7.16M | -$5.92M | -$6.96M |
| Purchases of Investments | -$117K | -$95K | -$90K | -$75K | -$75K | -$105K | -$75K | -$75K |
| **Investing Cash Flow** | $4.99M | -$16.00M | $7.28M | -$75K | -$7.39M | -$105K | -$75K | -$75K |
| Common Stock Issued | -- | -- | -- | -- | $13.56M | $14.71M | $4.69M | $11.67M |
| **Financing Cash Flow** | -- | -- | -- | -- | $13.56M | $14.71M | $5.22M | $11.96M |
| **Net Change in Cash** | $2.97M | -$23.02M | $27.19M | -$7.78M | -$1.97M | $7.45M | -$779K | $4.93M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -259.8% | -49.9% |
| Return on Assets (ROA) | -148.0% | -121.5% | -81.6% | -74.7% | -63.0% | -23.8% |
| Current Ratio | 2.76x | 5.01x | 0.49x | 14.96x | 45.00x | 103.81x |
| Quick Ratio | 2.57x | 4.49x | 0.12x | 11.81x | 43.64x | 102.88x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -148.0% | -113.3% | -88.2% | -219.6% | -121.5% | -114.3% | -123.8% | -159.3% |
| Current Ratio | 2.76x | 7.07x | 10.10x | 3.42x | 5.01x | 3.41x | 1.37x | 1.65x |
| Quick Ratio | 2.57x | 6.35x | 9.39x | 3.07x | 4.49x | 2.88x | 0.96x | 1.16x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -457.1% | -- | -196.7% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -100.7% | -- | -103.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
